PLNH · Planet 13 Holdings Inc.

$0.13 0.00 (-2.63%) At close · Aug 26

Market Cap

$43.42M

335.32M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue

$103.38M -11.2%

FY2025

Net Income

-$63.92M -33.7%

FY2025

Gross Margin

38.57% -9.6pp

FY2025

Operating Cash Flow

-$14.19M -372.4%

FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics

Annual Quarterly

Line Item	3Y	5Y	10Y	TTM	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	-0.4%	—	—	$92.44M	$103.38M	$116.41M	$98.51M	$104.57M	$119.49M
Net Interest Income	—	—	—	-$97.65K	-$476.72K	-$333.08K	$195.72K	$189.47K	-$18.88K
Cost of Revenue	+3.9%	—	—	$54.5M	$63.51M	$60.3M	$53.68M	$56.6M	$53.49M
Gross Profit	-6.0%	—	—	$37.94M	$39.87M	$56.11M	$44.82M	$47.97M	$66.01M
Gross Margin	—	—	—	—	38.57%	48.2%	45.5%	45.88%	55.24%
Selling & Marketing	+15.9%	—	—	$4.81M	$5.46M	$5.81M	$5.37M	$3.5M	$5.97M
General & Administrative	+1.5%	—	—	$46.5M	$51.62M	$51.17M	$42.42M	$49.4M	$59.93M
Amortization of Intangibles	—	—	—	—	—	—	$0	$372.22K	$0
Depreciation & Amortization	+0.4%	—	—	—	$11.4M	$13.41M	$12.15M	$11.26M	$7.21M
Other Non-Operating Income	—	—	—	$4.19M	$7.01M	-$90.59K	-$975.48K	-$2.04M	-$1.15M
Pretax Income	—	—	—	-$50.22M	-$52.28M	-$35.61M	-$62.08M	-$50.79M	-$8.98M
Income Tax	+10.0%	—	—	$12.04M	$11.64M	$12.19M	$11.53M	$8.75M	$13.48M
Net Income	—	—	—	-$62.26M	-$63.92M	-$47.8M	-$73.61M	-$59.55M	-$22.46M
Net Margin	—	—	—	—	-61.83%	-41.06%	-74.73%	-56.94%	-18.8%
Net Income Available to Common Stockholders	—	—	—	—	—	-$47.8M	-$73.61M	-$59.55M	-$22.46M
Comprehensive Income	—	—	—	—	—	—	-$73.61M	-$59.55M	-$22.46M
EPS (Basic) USD/shares	—	—	—	-$0.19	-$0.20	-$0.16	-$0.33	-$0.27	-$0.12
Shares Outstanding (Basic Avg) shares	+14.5%	—	—	—	325.34M	292.17M	221.96M	216.59M	195.13M

Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue

0.52×

Peer median 1.03×

EV/EBIT

—

Peer median 8.53×

P/E (TTM)

—

Peer medians compare against the 44 similar-size Drug Manufacturers - Specialty & Generic companies (of 101 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Product & Service (USD)

Component	FY2025	FY2024	FY2023
Retail	$92,960,702	$102,413,526	$81,323,306
Wholesale	$10,418,127	$13,995,440	$17,181,864

Key facts CIK 1813452 CUSIP 72707C108 13F (30d) 3 filings 3 filers Visit website Investor relations